Drug information provided by: Merative, Micromedex®
Voretigene neparvovec-rzyl injection is used to treat retinal dystrophy (a rare form of inherited loss of vision) with confirmed biallelic RPE65 mutation.
This medicine must be given only by or under the direct supervision of your doctor.
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!